ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
AH012710.2|Rubrivivax_1 # 3 # 1094 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.723	AH012710.2|Rubrivivax_1 	3	1094	+	Loose	700	30.4166	EreA2	27.1	3002826	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	CCCAGTGCCTCGGGCGTGCCGCTGCGCCTGCTGCCCAAGGAAATCGACGGCGTGCGCATCATCGGCATCGACGTGCCGGGTTTCGGCGTGCCGACGCATGCCGAGGCCAAGGACGTGCTCGCCGGCGCGATGCTGCGCGTGGCACGCGGCGAAGCCGAAGCCGGCCCGGTGGCCGCGCCGCGGGGCGGCGTCAGCGAGAAGCCGACCGTCACGCTGCTCGGCGAGATGTTCCCGGCCGACCCGGTGGGCATCGGCATGATGCTCGAGCCGATGGGCCTGGCCGCCGGCCCGGTGGTGCCGACGCGTGAATGGCGCGAGCTGTATGCCGCGCTGGACTGCGCCGCCGTCGCCGCGATCCACCCGTTCTACACCGCCAGCGTGCGCGAGTTCGAGACCGCGGGTCGCCCCGTCGTCGCCTCGGCGCCGGTGGGCCACGACGGCACCGAAGCCTGGCTGCAGGCCGTCGGCCGCGCCTGCAACGTGCCGCAGGCGATGATCGACGCGTCCAAGAACAAGTGGCTGCGGGCCATCAAGGGCGCGCTGGCCGCCACGCCGATCAAGGGCCGTGTCGTCGTCTCCGGCTACGAAGGCTCGGAGATGCTGGTCGCGCGTCTGCTCGTCGAGAGCGGCGCCGAGGTGCCCTACGTCGGCACCGCCTGCCCGAAGACGCCCTGGAGCGCGCCCGACCTCGAATGGCTGCAGGCGCGCGGCGTGCACGTGCAGTACCGCGCCTCGCTGGAGCAGGACATCGCCGCGGTGCGCGAATGCCGCCCCGACCTGGCGATCGGCACGACCCCGGTGGTGCAGGCCGCCAAGCAGGCGACGATCCCGGCGCTGTACTTCACGAACCTGATCTCCGCCCGCCCGCTGATGGGCCCCGCCGGTGCCGGTTCGCTGGCCCAGGTCATCAACGCGGCGATCGCCAACAAGTCGCGCTTCCAGCAGATGCGCGAGTTCTTCGGCGAGGTCGGCTCCGGCGACCAGGCCGGAGTCTGGGAAGACGTGCCCCGCCTTCGCCCCGAGTTCCGGGCCGAGACGCGCCGTCAGGTCATCAAGCTCCAGAAGCGCCGCAAGGCCGAGGAGATGATCTGA	PSASGVPLRLLPKEIDGVRIIGIDVPGFGVPTHAEAKDVLAGAMLRVARGEAEAGPVAAPRGGVSEKPTVTLLGEMFPADPVGIGMMLEPMGLAAGPVVPTREWRELYAALDCAAVAAIHPFYTASVREFETAGRPVVASAPVGHDGTEAWLQAVGRACNVPQAMIDASKNKWLRAIKGALAATPIKGRVVVSGYEGSEMLVARLLVESGAEVPYVGTACPKTPWSAPDLEWLQARGVHVQYRASLEQDIAAVRECRPDLAIGTTPVVQAAKQATIPALYFTNLISARPLMGPAGAGSLAQVINAAIANKSRFQQMREFFGEVGSGDQAGVWEDVPRLRPEFRAETRRQVIKLQKRRKAEEMI	MTWRTTRTLLQPQKLEFNEFEILNPVVEGARIVGIGEGAHFVAEFSLARASLIRYFVERHDFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSLYGSVLIWVKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQVIDHLMKPHVDALTQLLTSIDGQSAVISSAKWGELETAQQEKAISGVTRLKLRLASLAPVLKNHVNSDFFRKASDRIESIEYTLETLRVMKAFFDGTSLEGDTSVRDSYMAGVVDGMVRANPDVRIILLAHNNHLQKTPVSFSGELTAVPMGQHLAEREEGDYRAIAFTHLGLTVPEMHFPSPDSPLGFSVVTTPADAIREDSVEQYVIDACGKEDSCLTLTDDPMEAKRMRSQSASVETNLSEAFDAIVCVPSAGKDSLVAL	88.97	gnl|BL_ORD_ID|1429|hsp_num:0	1518		
AH012710.2|Rubrivivax_2 # 1094 # 2557 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GCC;rbs_spacer=14bp;gc_cont=0.692	AH012710.2|Rubrivivax_2 	1094	2557	+	Loose	570	29.6462	bcrA	27.71	3002987	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTACGTGATCGACCACGACCGCGCGGGCGGTTACTGGGGCGCGGTGTACGTGTTCACCGCGATCAAGGGGCTGCAGGTCGTCATCGACGGCCCGGTGGGCTGCGAGAACCTGCCGGCCACCGCCGTGCTGCACTACACCGACGCGCTGCCGCCGCACGAGCTGCCGATCGTCGTCACCGGCCTGGGCGAAGAGGAACTGGGCCGCGAAGGCACCGAAGGCGCGATGAAGCGCGCCCATTCGGTGCTCGATCCCGACCTGCCGGCCGTCGTCGTCACCGGCTCGATCGCCGAGATGATCGGCGGCGGCGTGACGCCCGAAGGCACGACGATCCAGCGCTTCCTGCCGCGCACGATCGACGAAGACCAGTGGCAATGCGCGAACCGCGCGATGTTCTGGCTGTGGAGCGAGTACGGCCTGCGCAAGATCCCGCAGCGCACCCCGTTCGAGCAGCGCCCGGCCGGCGAGAAGCCGCGCGTGAACATCATCGGCCCGAGCTACGGCACCTTCAACATGCCCAGCGACCTGGCCGAGATCCGCCGCCTGGTCGAAGGCATCGGCGCCGAGGTGAACATGGTGTTCCCGCTCGGCAGCCACCTGGCCGACGTGCAGAAGCTCGTCGACGCCGACGTCAACGTCTGCATGTACCGCGAGTTCGGCCGCATGCTGTGCGAGGCGCTGGAGCGCCCGTACCTGCAGGCGCCGATCGGCATGCACAGCACGACCGCGTTCCTGCGCGAGCTCGGCCGCCTGCTGAACCTGGACCCCGAGCCCTTCATCGAGCGCGAGAAGCACACCACGCTCAAGCCGATCTGGGACCTGTGGCGCTCGGTGACGCAGGACTTCTTCGGCACCGCCAACTTCGGCATCGTCGCCGGCGAGACCTACGCGCGCGGCGTGCGCCACTTCCTCGAAGACGAGCTGGGCCTGCCATGCAACTTCGCCGTCGCCCGCAAGGCCGGCGAGAAGACCGACAACGAGAGCGTGCGCGAGCTGGTGCACACGAAGACGCCGCTGGTGCTCTTCGGCAGCTACAACGAGCGCATGTACCTGGCGCAAACGACGCGCCGCCACGGCCCGAAGCCGGCCTACATCCCGGCCTCGTTCCCCGGCGCCATCATCCGCCGCCACACCGGTACGCCCTTCATGGGCTACTCCGGGGCGACCTACCTGGTGCAGGAGTTCTGCAACGCGCTGTTCGATGCGCTGTTCAACATCCTGCCGCTGGGCACCGAACTCGACCGCATCGACGCGACGCCCTCGCGCCGCGGCGACTCCAGGCCCTGGGACGACGAAGCCCAGCAGGTGCTGCGCGACTACGTCGCCCGCCAGCCGGTGCTGGTCCAGATTTCCGCTGCCAAGCAGCTGCGCGACCGCGCCGAACGCGAAGCCAGCGCCGCCGGCGAGGAACGCGTCACCGCGAGCCGCGTGCGCCAGCTGCTCGGTCAGAAGGAGCCCGCATGA	MYVIDHDRAGGYWGAVYVFTAIKGLQVVIDGPVGCENLPATAVLHYTDALPPHELPIVVTGLGEEELGREGTEGAMKRAHSVLDPDLPAVVVTGSIAEMIGGGVTPEGTTIQRFLPRTIDEDQWQCANRAMFWLWSEYGLRKIPQRTPFEQRPAGEKPRVNIIGPSYGTFNMPSDLAEIRRLVEGIGAEVNMVFPLGSHLADVQKLVDADVNVCMYREFGRMLCEALERPYLQAPIGMHSTTAFLRELGRLLNLDPEPFIEREKHTTLKPIWDLWRSVTQDFFGTANFGIVAGETYARGVRHFLEDELGLPCNFAVARKAGEKTDNESVRELVHTKTPLVLFGSYNERMYLAQTTRRHGPKPAYIPASFPGAIIRRHTGTPFMGYSGATYLVQEFCNALFDALFNILPLGTELDRIDATPSRRGDSRPWDDEAQQVLRDYVARQPVLVQISAAKQLRDRAEREASAAGEERVTASRVRQLLGQKEPA	MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVVLMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLIGGGTIG	159.15	gnl|BL_ORD_ID|322|hsp_num:0	345		
AH012710.2|Rubrivivax_3 # 2554 # 2700 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.633	AH012710.2|Rubrivivax_3 	2554	2700	+	Loose	1200	21.9422	otr(A)	31.25	3002891	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAACAGGGGCTCCGCTCACAGTTTCCTGTCCGCGATCAGTGGACGAACCGAATGTCGTGGCACTCTGCCGCGGCTGCCCACCGTGCGCGGGTTCTGTGCGCACGCGGCCGCTTGGCCGCTTATGAAGGAGTTTCCTCATGGCTGA	MNRGSAHSFLSAISGRTECRGTLPRLPTVRGFCAHAAAWPLMKEFPHG	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV	7.24	gnl|BL_ORD_ID|1221|hsp_num:0	1273		
AH012710.2|Rubrivivax_4 # 2693 # 2839 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.612	AH012710.2|Rubrivivax_4 	2693	2839	+	Loose	2000	21.1718	Staphylococcus aureus mupB conferring resistance to mupirocin	60.0	3000510	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGGCTGAAAGAAAGGGCTCGATCTCCGGGCTCACCGACGACGAAGCCCAGGAGTTCCACAAGTTCTGGGTCCAAGGTTTCGTGGGTTTCACGGCGGTCGCCGTCGTCGCCCACTTCCTGGTCTGGGTCTGGCGTCCCTGGCTCTAA	MAERKGSISGLTDDEAQEFHKFWVQGFVGFTAVAVVAHFLVWVWRPWL	MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN	4.65	gnl|BL_ORD_ID|2124|hsp_num:0	2271		
AH012710.2|Rubrivivax_5 # 3070 # 3195 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.532	AH012710.2|Rubrivivax_5 	3070	3195	-	Loose	375	20.7866	vanXI	42.11	3003725	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	GTGAATCAGAACGGCGAGACCGAGAAGGAACACCGCCTGGGCCACCATGGCGCGCATCGGATCGAACAGACGCCAAATTCTCCACATAATCCAAGCTCCTATAGCAAATGCGACATGAAGGTATAA	MNQNGETEKEHRLGHHGAHRIEQTPNSPHNPSSYSKCDMKV	MKSDFVFVDELVSGIRWDAKYATWDNFTGKPVDGYAANRIVGTRALCAALEKARENAASLGFGLLLWDGYRPQCAVDCFLRWSKQPEDGRTKQKHYPNIDRSEIIEKGYVAAKSGHSRGSAIDLTLYHLASGTLVPMGGDFDLMDSVSHHGAHGISQAEARNRQYLCSIMEASGFVSYACEWWHYSLKHEPYPNTYFDFLIA	20.30	gnl|BL_ORD_ID|2094|hsp_num:0	2243		
AH012710.2|Rubrivivax_6 # 3670 # 4266 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.621	AH012710.2|Rubrivivax_6 	3670	4266	+	Loose	800	29.6462	Chlamydia trachomatis intrinsic murA conferring resistance to fosfomycin	27.91	3003785	protein homolog model	n/a	n/a	fosfomycin	antibiotic target alteration	antibiotic-resistant murA transferase	ATGGAAGGCGGGCTCTGGCAGATCATCACGGTGTGCGCGATCGGTGCCTTTGTCTCCTGGGCGTTGCGTGAGGTCGAGATCTGCCGCAAGCTCGGCATGCAATACCATGTGCCGATCGCGTTCAGTTTCGCGATCCTGGCCTATGTCACGCTGGTCGTCATCCGCCCGATCCTGATGGGCGCATGGGGCCACGGTTTCCCCTACGGCATCTTCAGTCACCTCGACTGGGTGTCGAACGTCGGTTACCAGTACCTGCACTTCCACTACAACCCGGCGCACATGCTGGCGATCACGTTCTTCTTCACGACGACGCTCGCCATGTCCATGCACGGGGGTCTGATCCTGTCGGCGGCCAACCCGAAGAAGGGCGAGCCGATGAAGACGACGGATCACGAAGACACGTTCTTCCGCGACGCCGTCGGCTATTCGATCGGTTCGCTCGGTATCCACCGCCTGGGTCTTTTCCTGGCGCTGTCGGCGGCCTTCTGGAGCGCGGTCTGCATCGTGATCAGCGGTCCGTTCTGGACGCGTGGCTGGCCGGAGTGGTGGGGCTGGTGGCTGAATCTGCCGATCTGGAGTCAGTGGCCGCTCAACTGA	MEGGLWQIITVCAIGAFVSWALREVEICRKLGMQYHVPIAFSFAILAYVTLVVIRPILMGAWGHGFPYGIFSHLDWVSNVGYQYLHFHYNPAHMLAITFFFTTTLAMSMHGGLILSAANPKKGEPMKTTDHEDTFFRDAVGYSIGSLGIHRLGLFLALSAAFWSAVCIVISGPFWTRGWPEWWGWWLNLPIWSQWPLN	MPGIKVFGETVLRGSVRVSGAKNATTKLLVASLLSDQRTILKNVPNIEDVRQTVDLCRVLGAIVEWDQQAQVIEIHTPRILLSKVPPQFSCVNRIPILLLGALLRRCPYGIFVPILGGDAIGPRTLHFHLEGWKKLGAEIVISDEGYWASAPNGLVGAHITLPYPSVGATENLILASVGAQGRTIIKNAALEVEIIDLIVFLQKAGVEITTDNDKTIEIFGCQDFYSVEHFIIPDKIEAASFGMAAVVSQGRIFVEQARHEHMIPFLKVLRSIGGGFSVHENGIEFFYDKPLKGGVLLETDVHPGFITDWQQPFAVLLSQSEGCSVIHETVHENRLGYLKGLVKMGAHCDLFHECLSAKSCRYSTGNHPHSAVIHGPTPLQATDLVIPDLRAGFAYVMAALIAEGGASWIENTEMLDRGYTDWRGKLERLGAKVLARDAVSVYV	44.59	gnl|BL_ORD_ID|2414|hsp_num:0	2291		
AH012710.2|Rubrivivax_7 # 4285 # 5262 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=CCC;rbs_spacer=14bp;gc_cont=0.672	AH012710.2|Rubrivivax_7 	4285	5262	+	Loose	550	26.9498	y56 beta-lactamase	21.0	3003558	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	BlaA beta-lactamase	ATGGCTGAATATCAAAACATCTTCACGCGTGTGCAGGTCGCAGGGCCGGCGCACATGGGCGTGCCGCTGCCCGAACGGGACAGCCCGCGCACCGGCAAGAAGCCTTGGCAGATCCACCTGCTGGGTCGCCTGGGCATGGCGCAGATCGGCCCGATCTACCTGGGCGCGCTGGGCATCCTGTCGATCGTCTTCGGCAGCCTGGCGACGATGATCATCGGCTTCAACATGCTGGCTTCGGTCGGCTGGAACCCGATCGAGTTCTTCCGCCAGTTCTTCTGGCTGGCGCTCGAGCCGCCGTCTCCGAAGTACGGCCTGAAGCTGCCGCCGCTGAACGACGGTGGCTGGTGGCTGATGGCAGGCCTGTTCCTGACGATCTCCATCCTGCTGTGGTGGGTCCGCATGTACACCCGCGCCCGCGCCCTGGGCATGGGCACGCACGTGGCCTGGGCGTTCGCCGCCGCGATCTGGCTGTACCTGGTCCTGGGCTTCATCCGCCCGGTGCTGATGGGCAGCTGGTCCGAGGCCGTGCCGTTCGGCATCTTCCCGCACCTGGACTGGACCGCCGCGTTCTCGCTGCGCTACGGCAACCTGTTCTACAACCCGTTCCACGCGCTCTCGATCGCCTTCCTGTACGGCGCGACGCTGCTGTTCGCGATGCACGGTGCGACGATCCTGGCCGTCAGCCGCTTCGGTGGCGAGCGTGAACTGGAGCAGATCGCCGACCGCGGCACCGCCTCGGAACGCGCCCAGCTGTTCTGGCGCTGGACGATGGGCTTCAACGCGACGACCGAGTCGATCCACCGCTGGGCGTGGTGGTTCGCCGTGCTGTGCCCGCTGTGCGGCGGCATCGGCATCCTGCTGTCGGGTACCGTCGTCGACAACTGGTATCTGTGGGCCGTGAAGCACGGCGTGGCACCGTCCTACCCGGCGGTGTTCGCGCCCACGATCGACCCCGCCACCCTGCAGGGAGTCAAGTGA	MAEYQNIFTRVQVAGPAHMGVPLPERDSPRTGKKPWQIHLLGRLGMAQIGPIYLGALGILSIVFGSLATMIIGFNMLASVGWNPIEFFRQFFWLALEPPSPKYGLKLPPLNDGGWWLMAGLFLTISILLWWVRMYTRARALGMGTHVAWAFAAAIWLYLVLGFIRPVLMGSWSEAVPFGIFPHLDWTAAFSLRYGNLFYNPFHALSIAFLYGATLLFAMHGATILAVSRFGGERELEQIADRGTASERAQLFWRWTMGFNATTESIHRWAWWFAVLCPLCGGIGILLSGTVVDNWYLWAVKHGVAPSYPAVFAPTIDPATLQGVK	MKHSSLRRALLLAGITLPLVNFSLPTWAAAIPGSLDKQLAALEHSANGRLGIAMINTGNGTKILYRGARRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAHGMTVSELCAATIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPNDPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTDWIVGDKTGSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATKIILSQIS	110.54	gnl|BL_ORD_ID|928|hsp_num:0	980		
AH012710.2|Rubrivivax_8 # 5262 # 6362 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.675	AH012710.2|Rubrivivax_8 	5262	6362	+	Loose	550	31.5722	BAT-1	24.75	3004747	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	BAT Beta-lactamase	ATGGCACTCGCGGTTCGCATTTCGACCCTTACCGTCGCCGTGACCGCGGCGGCCCTGCTCGCGGGATGCGAGCGTCCGCCGGTCGATGCCGTGCAGCGTGGTTACCGTGGCACGGGCATGCAGCACATCGTCAACCCGCGCACGCTGGCTGAACAGATCCCGACCCAGCAGGCCCCGGTGGCCACTCCGGTGGCCGACGACTCGGGCCCGCGCGCCAACCAGGTGTTCCAGAACGTCAAGGTCCTGGGCCACCTGTCGGTCGCGGAGTTCACGCGCCAGATGGCGGCGATCACCGAGTGGGTGTCGCCGACCGAGGGCTGCAACTACTGCCATACCGAGAATCTGGCCGACGACTCGAAGTACCAGAAGGTCGTCTCCCGCCGGATGCTCGAGATGACGCAGAAGGTCAACACGCAGTGGACGCAGCACGTCGCCGCCACCGGCGTCACCTGCTACACCTGCCACCGCGGCAACCCGGTCCCCAAGGAGGTCTGGTTCACCGCGGTGCCGCAGAACAAGCGTGCTGACTTCATCGGCAACCTCGACGGCCAGAACCAAGCCGCCAAGGTCGTCGGGCTGACCTCGCTGCCCTACGATCCGTTCACGACCTTCCTGAAGGAAGACACGAACGTCCGGGTCTACGGCACGACGGCGCTGCCGACGGGCACTTCGAAGGCCGACATCAAGCAGGCCGAGAAGACCTACGGCCTGATGATGCACTTCTCGGGTGCGCTGGGCGTCAACTGCACGTACTGCCACAACACCAACGGCTTCGGCAGCTGGGACAACGCCGCGCCGCAACGCTCGACGGCCTGGTACGGCATCCGCATGGCGCGTGGCCTCAACAACGGCTTCATGGAAGGCCTGACCAAGAGCTTCCCGGCACATCGGCTGGGCCCGACGGGCGACGTGGCGAAGATCAACTGCGCCACCTGCCACCAGGGTGCCTACAAGCCGCTGTACGGCGCGCAGATGGCCAAGGACTATCCGGGCCTGAAGCCGGCACCGGCGGCGCCCGCCGCCTCTGCCGTGGAAGCCGCTGCCGTCGACGCCGCCGCGTCGGCTGCTCCGGTCGCCACGGTGGCCACCGCCTCGAAGTAA	MALAVRISTLTVAVTAAALLAGCERPPVDAVQRGYRGTGMQHIVNPRTLAEQIPTQQAPVATPVADDSGPRANQVFQNVKVLGHLSVAEFTRQMAAITEWVSPTEGCNYCHTENLADDSKYQKVVSRRMLEMTQKVNTQWTQHVAATGVTCYTCHRGNPVPKEVWFTAVPQNKRADFIGNLDGQNQAAKVVGLTSLPYDPFTTFLKEDTNVRVYGTTALPTGTSKADIKQAEKTYGLMMHFSGALGVNCTYCHNTNGFGSWDNAAPQRSTAWYGIRMARGLNNGFMEGLTKSFPAHRLGPTGDVAKINCATCHQGAYKPLYGAQMAKDYPGLKPAPAAPAASAVEAAAVDAAASAAPVATVATASK	MKKRKMPAVFLALIGAAGLLFTTSVQPISEASAAEKNLNIKKLDVDEFFADHNGTFILRDMNKGKTFIYNHERANQRFAPQSTFKVPNALIGLQVGAVEDEYSIKYWDGVKREIDIWNQDHTLGSGMRHSVVWYYQAMARDIGESRMKEWIEKISYGNQDISGGIDQFWLSSTLKISPIEQADFMERLYKENLPFDKDVMKTVKRMMIQEEEDHSTLYGKTGSGTGIGWFFGFVKIDNRAYSFVTNIDGTGAEAKNITMDILKKYKLY	136.57	gnl|BL_ORD_ID|2470|hsp_num:0	3558		
AH012710.2|Rubrivivax_9 # 6405 # 7175 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GCC;rbs_spacer=13bp;gc_cont=0.726	AH012710.2|Rubrivivax_9 	6405	7175	+	Loose	525	27.335	LRA-1	28.21	3002482	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class A LRA beta-lactamase	ATGACGAACGAACTCAGCAACGCCGCCGGCGCCTCGCAACAGGGCCCGGCGGCTTCTTCTTTTTCCGCCGACACGCCGCCCCGGACCACCGCCGGTGGCGACGTGCTCGTCCTGTTGCTGATCGACGTGGCCCCCGCCGCGCGCCTGTGGGGCTACGGCCGCTTCGTCGCTGGCACCACGCCGGCGCTGGGCGAGCCCGGAGCCCGTTTCGCCAAGCAGCTCGGAACCGGCTACGAGGGCGGTTTCGGCCTGCGCCCCAGCGCCACGCGGCAGGGCTTGTTCGTGCTCTTCGAGGACGAGGCCGCGGCCGACGCCTTCATCGGCCGATCCGAGCTCGTCCAGACCTACCGCCGCAACGCGCGCGAGCTGTGCATCGTGAAGGCGCGGCCGTACAGCGCCCGCGGCAGCTGGGACGGCCAGAAGCTCCGTGTCGGCTCGCCGGCGCCTGTCGACGGGCCGGTGGCGGCGCTGACGCGCGCTTCGATCCGCCCGTCGCAGGCGCACCGTTTCTGGCCCAACGCCGGGCCCTCGCAGGACTCGCTCGAACGTGCCGCCGGCTGCCGTCTGGCCGTCGGCCTGGGCGAGGCACCGTTCCTGCGCCAGGCCACCTTCAGCGTGTGGGACAGCGTCGCCGCGATGGACGCGTATGCGCGCACCGGCGCGCACCAGCGGGCGATCGTCGCCTCGCGCGACTTCTTCTCCGAGTCGATGTTCGTGCGCTTCGTGCCGCTGTCCATCGAGGGCGTCTGGAAGGGCCGGCGCTATGGCTGA	MTNELSNAAGASQQGPAASSFSADTPPRTTAGGDVLVLLLIDVAPAARLWGYGRFVAGTTPALGEPGARFAKQLGTGYEGGFGLRPSATRQGLFVLFEDEAAADAFIGRSELVQTYRRNARELCIVKARPYSARGSWDGQKLRVGSPAPVDGPVAALTRASIRPSQAHRFWPNAGPSQDSLERAAGCRLAVGLGEAPFLRQATFSVWDSVAAMDAYARTGAHQRAIVASRDFFSESMFVRFVPLSIEGVWKGRRYG	MNPPIHRRTLLLAASVLPLASACTAWSAKGPQQDASAQLAALEAASGSRLGVVGFNTATGARVQHRAEERFPFCSTFKLMLAAAVLERSAKEGDLLARRVNYSKGDLVSYSPITEKNVATGMTVAELCAATVQYSDNGAANLLMKILGGPSAVTAFARASGDEVFRLDRWETELNTAIPGDLRDTTTPAAMAASVQRLVLGNALGAAQREQLKTWLLGNTTSTQRFLAGVPAGWKVGDKTGSGSYGTTNDVGVLWPPAGAPLVLAVYLTFPQKEAKGRSDVVASATRIAVSALAS	86.78	gnl|BL_ORD_ID|1504|hsp_num:0	1601		
AH012710.2|Rubrivivax_10 # 7168 # 8745 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.723	AH012710.2|Rubrivivax_10 	7168	8745	+	Loose	800	32.7278	tet(48)	42.86	3004581	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGGCTGAGGCCTGGCGCACGCACCGTGTCGTTGTCGTCGGTGCCGGCATCGCCGGGCTCAGCAGCGCTCTGCTGCTGGCCGCGCGCGGCCTGGACGTAACGCTCGTCGACAAGTCGGCCACCCCGGGCGGCAAGATGCGCCAGGTGCTGGTCGACGGCTCGCCCGTCGACGCCGGTCCGACGGTGTTCACGATGCGCTGGGTCTTCGACCAGATCTTCGCCGCCGCCGGCGCGAAGGTCGAGGACCACCTGAAGCTGCAGCCGCTGGGCGTGCTCGCGAGGCACGCCTGGCGCGGCCACGAGCCGCGCCTGGACCTTTTCGTCGACATCCGGTGCTCGGCCGAGGCGATCGGCGAGTTCAGCGGCCCGCAGGAGGCCCAGCGTTTCCTCGGCTTCTGCGGCCAGGCGCGCCAGCTCTACGACCACCTCGAAGGTCCGTACATCCGCTCCGAGCGCCCGACGCTGGGCAGCATGGTCGGCGACCTCGGGCCGCGCGGCCTGATGGCGCTGATGCAAGATCGGCCCGTTCTCCAACCTCTGGCGCTGCTGTCGCGGCATTTCCGCGATCCGAAGCTGCAGCAGCTGTTCGCGCGCTACGCCACCTACTGCGGCGCCTCGCCGTGGATGGCGCCGGCGACGCTGATGCTGGTCGCCCAGGTCGAGCTCGACGGCGTCTGGGCCGTCGAGGGCGGCATGCACGCCGTCGCCAAGGCCTTCTCGGCGCTGGCCGAGGCCCGGGGCGTGAAGACGCGCTACGGCTGCGGCTGCGAGCAGGTGCTCGTGCGCGACGGGCGCGCGGTCGGCGTGCGCCTGGCCGGCGGCGAGGAGATCGCCGCCGACTCGGTCGTCTTCAACGGCGACGTCAATGCGCTCGCCCAGGGCCTGCTGGGCGACCCGGCGCGCCGCGCCACGGCGTCTGTCGCGCCCGCCAGGCGCTCGCTCTCGGCGCTGACCTGGCTGGTCAACGCCCGCACCAGCGGCTTCCCGCTGGTGCGCCACAACGTGTTCTTCGACGAGGACTACGCGTCCGAGTTCGACGACATCTTCCGCCAGCGCCAGCTCCCGCGGCGCGGCACCGTCTACGTCTGTGCGCAGGACCGCACCGACGAAGGAATCGGGTCGGACGCTCCCGAGCGCCTGCTGTGCCTGGTCAATGCGCCGGCCGACGGGGACCGACGGCCCTTCGACCTCTCGGAGACCGAACCATGCGAGCAGCGGAGTCTGGCGCTGATGCGCGAGTGCGGCCTGTCGATCGAGTGGAGCCCGCAGACGCACCGGCTGGTGACGCCGGCGGACTTCGAGCGGCTGTTCCCGGCGACGGGGGGAGCGCTGTACGGCCCGGCGACGCACGGCTGGATGTCCTCGTTCCACCGGGCCTCGTCGACGAGCCGGCTGCCGGGGCTTTACCTGGCGGGGGGCAGCGTGCACCCGGGGCCGGGCGTGCCGATGGCGGCGATGTCCGGCCGGTTGGCGGCCGAGACGCTGATGGCGCACCTCGATTCGACCAACCGGTCCCGCCGGGTGGTTATCTCTGGTGGTATGTCGACGCGGTCAGCGACGACGGGCGGCATGGCCTGA	MAEAWRTHRVVVVGAGIAGLSSALLLAARGLDVTLVDKSATPGGKMRQVLVDGSPVDAGPTVFTMRWVFDQIFAAAGAKVEDHLKLQPLGVLARHAWRGHEPRLDLFVDIRCSAEAIGEFSGPQEAQRFLGFCGQARQLYDHLEGPYIRSERPTLGSMVGDLGPRGLMALMQDRPVLQPLALLSRHFRDPKLQQLFARYATYCGASPWMAPATLMLVAQVELDGVWAVEGGMHAVAKAFSALAEARGVKTRYGCGCEQVLVRDGRAVGVRLAGGEEIAADSVVFNGDVNALAQGLLGDPARRATASVAPARRSLSALTWLVNARTSGFPLVRHNVFFDEDYASEFDDIFRQRQLPRRGTVYVCAQDRTDEGIGSDAPERLLCLVNAPADGDRRPFDLSETEPCEQRSLALMRECGLSIEWSPQTHRLVTPADFERLFPATGGALYGPATHGWMSSFHRASSTSRLPGLYLAGGSVHPGPGVPMAAMSGRLAAETLMAHLDSTNRSRRVVISGGMSTRSATTGGMA	MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFGIAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIEILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKEEYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDNIRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVATQIKMKSWTKGRIALVGDSGYCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINETFLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK	131.58	gnl|BL_ORD_ID|2777|hsp_num:0	3284		
AH012710.2|Rubrivivax_11 # 8883 # 9593 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GCC;rbs_spacer=15bp;gc_cont=0.719	AH012710.2|Rubrivivax_11 	8883	9593	+	Loose	1500	26.1794	rphB	29.49	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGACCGAACGCGGCCGGCGCTGGATGCGGCGCAGCCGCGACGAGTTCGTCATCGGCCCGAGCCGGCTGCACTGGGACGGCGAGTCGCTGCTCGTCGAGTTCGACGAGGTCGGCGTGCCGATCCCGCGGCGCGTGAAGGGCCGGGTGCGCGTCTGGCCGAAGGCGCTGTGCCGCTTCGTCACCTCGCTGGACAGCGGCGGACGCCATCGCTGGGGGCCGATCGCGCCTTGCAGCCGCATCGAGGTCGAACTCGACAGCCCGCGTGTGCGCTGGAGCGGCCACGCCTACCTCGACTCGAACGAAGGCGACGAGCCGATCGACCGCCCGTTCCGCGAGTGGGACTGGTCGCGCGCCACGATGGCCGACAGCAGCACCGCGGTGATCTACGACGTGCGCCAGAAGCGCGACGGCGATCGCGTGATCGCCGAGCGTTTCCTGCTCGACGGCAGCACCGAGAGCTTCGAGGCGCCGCCGCGGCAGCCGCTGCCGACGACGCTGTGGCGCATCGGCCGCACGATGCGTACCGAGCCCGGCGTGCCGGCGCTCGTCGAGCAGACGCTGGAGGACACGCCGTTCTACGCGCGTTCGATGGTGCGTTCGGGGCTGCTCGGCGAGGTCGTGACCTCGGTGCACGAGACGATGCTGCTGCCGCGCGTGATCACGCTGCCGGTGCGGCTGATGCTGCCCTGGCGCATGCCGCGCCGCGCTTGA	MTERGRRWMRRSRDEFVIGPSRLHWDGESLLVEFDEVGVPIPRRVKGRVRVWPKALCRFVTSLDSGGRHRWGPIAPCSRIEVELDSPRVRWSGHAYLDSNEGDEPIDRPFREWDWSRATMADSSTAVIYDVRQKRDGDRVIAERFLLDGSTESFEAPPRQPLPTTLWRIGRTMRTEPGVPALVEQTLEDTPFYARSMVRSGLLGEVVTSVHETMLLPRVITLPVRLMLPWRMPRRA	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	26.70	gnl|BL_ORD_ID|2298|hsp_num:0	2528		
AH012710.2|Rubrivivax_13 # 10001 # 11035 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.751	AH012710.2|Rubrivivax_13 	10001	11035	-	Loose	500	26.5646	BPU-1	24.47	3004759	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BPU Beta-lactamase	ATGCCCGCTGACCTGCGCGTCTCGTCCGAGTTGCAGGCCTGCCGCGAACTGATGCGCGGCGGCTCGAAGTCCTTCTTCGCCGCGTCGCTGCTGCTGCCGCAGCGCGTGCGGGCGCCCGCCACCGCGCTGTACGCCTTCTGCCGCGTCGCCGACGACGCGGTCGACCTGAGCGGCGACCCGCACGCGGCGATGGCCGAGCTGCGCACGCGGCTGGACGGCGTCTACGCCGGCACGCCGGCGCCGATCGCCGCCGACCGCGCGCTGGCCTGCACGGTGCACCGCTACGGCGTGCCCCGCGTGCTGCTCGACGCGCTGCTCGAAGGCTTCCTCTGGGACGCCGACGGCCGCCGCTACGACACCATCGCCGACGTCGAGGCCTACGGCGCCCGTGTCGCCGGCACCGTCGGCGCGGCGATGGCGCTGATCATGGGCGTGCGCTCGCCGCAGGCCCTGGCGCGCGCCTGCGAGCTGGGCGTCGCGATGCAGTTCACCAACATCGCGCGCGACGTCGGCGAGGATGCGCGCAACGGCCGGCTGTACCTGCCGCGCGGATGGCTGGTCGAAGCCGGCCTGGACGTCGACGCCTGGCTGCAGAACCCGGTGCACTGCCCGCCGGTCGCGCAGACCGTGCGCCGGCTGCTGCGCGCCGCCGACGAGCTGTACGAACGGTCCGAGCACGGCATCGCCGCCCTGCCCCGCGACTGCCGCCCGGCGATCCGCGCCGCGCGCCTGGTCTACGCCGAGATCGGCAAGCGCCTGGAGCGCGACGGCCTGGACTCGGTGAACCGCCGCGTCGTCGTGCCGGCGCGCCGCAAGGCCGCACTGATGGCCCGTGCCGCGTCCGCCGCCTTCAACACGCCCGGGCGCGCCTACATCTCGATGCCGCCGCTGCCGGCCATCCAGTACCTGGTCGACGCCTCGGTCGCCGCACCGGGCCCGACGGTGCCGCACCGCCCGCCGCAGCGTTCCTTCGACGAACGCATCGGCTGGGTCATCGAACTGATGGAACGCCAGGCCGCACGCCGCGGCATCTGA	MPADLRVSSELQACRELMRGGSKSFFAASLLLPQRVRAPATALYAFCRVADDAVDLSGDPHAAMAELRTRLDGVYAGTPAPIAADRALACTVHRYGVPRVLLDALLEGFLWDADGRRYDTIADVEAYGARVAGTVGAAMALIMGVRSPQALARACELGVAMQFTNIARDVGEDARNGRLYLPRGWLVEAGLDVDAWLQNPVHCPPVAQTVRRLLRAADELYERSEHGIAALPRDCRPAIRAARLVYAEIGKRLERDGLDSVNRRVVVPARRKAALMARAASAAFNTPGRAYISMPPLPAIQYLVDASVAAPGPTVPHRPPQRSFDERIGWVIELMERQAARRGI	MKKKYIKRLFSCIMLMAFCISQPSSTEARSIAWSVDEFFKNREGTFVIQEVKEKSPWVYNKKRAKERFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDNWNRDHTLGSGMRDSVVWYYQAMARDIGEERMNHWVKAIHYGNKDISGGIDQFWLSSTLRISPIEQVRFLKQLYEETLPFDLKNMRTVKRMMVQEEEKHATLYGKTGSGSDIGWYVGFIKHEHKTYILATNIKGTGIEAKDITYRILKKYHLMEASV	131.30	gnl|BL_ORD_ID|2616|hsp_num:0	3564		
AH012710.2|Rubrivivax_14 # 11025 # 11858 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.692	AH012710.2|Rubrivivax_14 	11025	11858	-	Loose	1850	26.5646	mdtF	38.98	3000796	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATGCTGAGCGTGGCGATCCCGGTGCTGTTCGCGGTGTTCGTCTGGTGGTTCAGCACCGGGCTGATCCTGTTGCTGGACGGGCTGCCGCGGAAGACCTTCCGCTGGAGCCTGGTCATCTCGACCGCCCTGGCGGCCACGGCCTTCGGCGCGCTGGTGCACACCGCCGGCAACACGACGCCGGCCGACGCGTACTGCGCCTTCACCTGCGCGCTGCTGGTCTGGGGCTGGCACGAGCTGGCCTTCCTGACGGGCTGGATCACCGGCCCGCGCAAGACCGCCACGCCGGCCGGTGCCAGCACCTGGACGCGCTTCGTGCACGCCATCCAGGCCATCCTGTGGCACGAGATCGCCATCATCAGCGTCGGCGTGGCCATCATCGCCGTCACCTGGGGCGAGCCCAACCAGGTCGGCACCTGGACCTACCTCGTGCTCTGGACCATGCGCGCCAGCGCCAAGCTCAACCTGTTCCTGGGCGTGCGCAACCTGAGCGAGGAGTTCCTGCCGGAGCACCTGAAGTACCTCGTCAGCTTCTTCCGCCGGCGGGCGATGAACCTGCTGTTCCCGATTTCGGTCACGGTGCCCACCGTCATCGCCGGCCTGATGGTCCAGGAGGCGCTGCTGCCGGCCACCGCGCCGGCGATGCACGTCGGCCTGCTGCTCGTCGCAACGATGCTCGGCATGGCCGTGATCGAACACTGGATGATGGTCCTGCCGCTGCCGGTCGCCGCGCTGTGGCGCTGGGCCCTGCGTTCGCGCGAGCCGGGGGAGCCGCACGATCCTCCCCCGCTGCTCGTGCCCCCTTCCGACAACAACCTGCTCCATGCCCGCTGA	MMLSVAIPVLFAVFVWWFSTGLILLLDGLPRKTFRWSLVISTALAATAFGALVHTAGNTTPADAYCAFTCALLVWGWHELAFLTGWITGPRKTATPAGASTWTRFVHAIQAILWHEIAIISVGVAIIAVTWGEPNQVGTWTYLVLWTMRASAKLNLFLGVRNLSEEFLPEHLKYLVSFFRRRAMNLLFPISVTVPTVIAGLMVQEALLPATAPAMHVGLLLVATMLGMAVIEHWMMVLPLPVAALWRWALRSREPGEPHDPPPLLVPPSDNNLLHAR	MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDSVTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPEAVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGSEYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRLQTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANALDTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQNFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVIAEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLLSVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYMVVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKEKDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAVVFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLEDTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRMLPDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMKFMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVMLVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIEAIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFVPVFFVVVEHLFARFKKA	26.71	gnl|BL_ORD_ID|106|hsp_num:0	121		
AH012710.2|Rubrivivax_15 # 11869 # 12945 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.652	AH012710.2|Rubrivivax_15 	11869	12945	-	Loose	550	28.4906	SHV-100	27.59	3001338	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	ATGCTCGCGACCCCGACGATCGAATCACCCGAAGAGGCCGCCCGCCGGGCCAAGGAGAGCACGCTCCTGAGCCCGCGCTTCTACACCACGGACTACGCCGCGATGAACGCGATCGACGTCTCGTCGATCCGAGCGGAGTGGGACGCGATGCTGGCCGAGTACGAGGGCGACAACAACCACGACCACTTCCAGCGCACGCCCGAGTTCGCGCAGGAGGTGGCCGAACGTTTCTCCCAGGTGTCGCCTGAGCTGCGCCAGGAATTCCTGGACTTCCTGGTGTCGTCGGTGACGTCCGAGTTCTCCGGCTGCGTTCTCTACAACGAGATCCAGAAGAACGTCGAGAACCCCGACGTCAAGGCGCTGATGCGCTACATGGCGCGCAACGAGTCGCGCCACGCCGGGTTCATCAACCAGGCGTTGCGCGACTTCGGCCTGGGCATCAACCTGGGCGGCCTGAAGCGCACCAAGGCCTACACCTACTTCAAGCCGAAGTACATCTTCTACGCGACCTACCTGTCCGAGAAGATCGGCTACGCGCGCTACATCACGATATACCGTCAGCTCGAGCGCCATCCGGACAAGCGTTTCCACCCGATCTTTCGCTGGTTCGAGCGCTGGTGCAACGACGAATTCCGCCACGGAGAGTCGTTCGCGCTGATCCTGCGCGCGCATCCACACCTGATCTCGGGCGCCAACCTGCTGTGGGTGCGTTTCTTCCTGCTGGCCGTGTACGCGACGATGTACGTGCGCGACCACATGCGGCCCCAGCTGCACGAGGCGATGGGGCTCGAGTCGACCGATTACGACTACCGCGTCTTCCAGATCACCAACGAGATCTCCAAGCAGGTCTTCCCGATCTCGCTGGACATCGACCATCAGGCGTTCCGCGCCGGCATGGAGCGCCTGGTGCGCGTGAAGACCAAGGTGGATGCCGCCAAGGCGCGCGGCGGCCTCGTCGGCCGCCTGCAGCAGGCGGCGTGGGCCGCGGCCGGCGCCGCGACCTTCGCCCGCATGTACCTGATCCCGGTGCGCCGTCACGCGCTGCCGGCCCAGGTGCGCATGGCACCGGCATGGTGA	MLATPTIESPEEAARRAKESTLLSPRFYTTDYAAMNAIDVSSIRAEWDAMLAEYEGDNNHDHFQRTPEFAQEVAERFSQVSPELRQEFLDFLVSSVTSEFSGCVLYNEIQKNVENPDVKALMRYMARNESRHAGFINQALRDFGLGINLGGLKRTKAYTYFKPKYIFYATYLSEKIGYARYITIYRQLERHPDKRFHPIFRWFERWCNDEFRHGESFALILRAHPHLISGANLLWVRFFLLAVYATMYVRDHMRPQLHEAMGLESTDYDYRVFQITNEISKQVFPISLDIDHQAFRAGMERLVRVKTKVDAAKARGGLVGRLQQAAWAAAGAATFARMYLIPVRRHALPAQVRMAPAW	MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIESESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	119.73	gnl|BL_ORD_ID|545|hsp_num:0	583		
AH012710.2|Rubrivivax_16 # 12964 # 13428 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.708	AH012710.2|Rubrivivax_16 	12964	13428	-	Loose	250	23.8682	CrcB	45.83	3005049	protein homolog model	n/a	n/a		antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGAGCGACAACGCGTCCCGCTCCCAGGATCTGCCGCGTGCACCGCTGATCGCCATCGGCGTGCTGCTCGTTGCCGTCATCGTCGGCGTTGCCGCGGTGCGCATGAGCGGGCAGACCATTCGCGCGCCCGACGGCGATGCCGTCGCGACGCGTGCCCTCCGATTCGAGGATCGTCCTGACGGCAGCATCGCCGTCATCGATGGGCGCGACGGCGCCCTGCTCGATTCGGTCCAGGGCGAGGCCGGGTTCCTCCGTGGGGCCCTGCGTGCACTCGCCCGCGAACGCATGAAGCGGGGCCTGGGCCCCGAGCAGGCGTTCGAACTCGTCGCCCGGAACGACGGTCGACTGACGCTGATGGACCCGGCAACGGGCCAGCGCATCGACCTGGAGTCCTTCGGCCCGACCAACGCCGGCGTGTTCGCACGTCTGCTGAAGGTCGAACCCCAGCCGGCTGCGGCCCGCTGA	MSDNASRSQDLPRAPLIAIGVLLVAVIVGVAAVRMSGQTIRAPDGDAVATRALRFEDRPDGSIAVIDGRDGALLDSVQGEAGFLRGALRALARERMKRGLGPEQAFELVARNDGRLTLMDPATGQRIDLESFGPTNAGVFARLLKVEPQPAAAR	MLNFTILIFVGGAFGAICRELLMLVVPRLSDGFPLDIFIANIIAAFLLGLCTSLYKRNRVNQYIHMMVATGIMGGLSTFSSFVSGAVEMMNEPLSALIAICYLVISLIVGFMAVELGLRLGSRVKPAPPMTHNRSTG	112.41	gnl|BL_ORD_ID|2839|hsp_num:0	3792		
AH012710.2|Rubrivivax_17 # 13425 # 14108 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	AH012710.2|Rubrivivax_17 	13425	14108	-	Loose	710	25.0238	tet(35)	33.33	3000481	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGACACACGGCCACCGGCACACCACCGGGCACGAGCACGATTACGAGCCCGTGCACGGACTGCCGGAGGTCCTCCCTGCCGAGGAGCACATCCTCTGGCAGGGCAGTCCCGATTGGCGCGCCCTCGCACGGCGCGCCTTTCACGTGCCTGCGCTGGTGCTGTATTTCGCCGCCGTCCTGGCGGCCCGTGCCGGTTACGTGCTGAGCCAGGGCGGCAGCGCCGGCGATGCACTGCGCGCGCTCGTCGTACTGCTGCCTCTGGTCTTCTTCGCGCTCGTGCTGATCACCGGGCTCGCCTGGCTGACCGCGCGTGGCGCCGTCTACACCATCACCGACCGGCGCATCGTCATGCGCATCGGCATCGTGCTGACGGTGACCTTCAACATTCCGTTCAAGCGCATCGCCGCCGCCGGCCTGCGCCGTCACCGTGACGGCAGCGGCGACATCCCGATCACGCTCGTCGGAGGCGACCGCATCGCCTACCTGCACCTCTGGCCGCATGCCCGCCCGTGGCGCTACGCCAGGCCGGAGCCGATGCTGCGCTGCGTTCCCGATGCCGAGGCGGTGGCCCGGCAGCTGTCGGAGGCCTGGTCGCGGGCCAACGCGCTGCCCGCCGTGCCCGCGTCCACGACCGACGGCAGCGCTGCCGCCGGCAAGCTTGCAGGACATGGTGCCGCCGCATGA	MTHGHRHTTGHEHDYEPVHGLPEVLPAEEHILWQGSPDWRALARRAFHVPALVLYFAAVLAARAGYVLSQGGSAGDALRALVVLLPLVFFALVLITGLAWLTARGAVYTITDRRIVMRIGIVLTVTFNIPFKRIAAAGLRRHRDGSGDIPITLVGGDRIAYLHLWPHARPWRYARPEPMLRCVPDAEAVARQLSEAWSRANALPAVPASTTDGSAAAGKLAGHGAAA	MCVIMPASSWGAYIITIIGGILVSHGITEYSALGAYVRLIPMNFYAVFALLMVFAVAWFGLDIGKMREHEIAASQGRGFDKDKENDSQEAHDLNEELDIRESEKGKVSDLILPIVTLIVATIASMLYTGGQALAADGKEFVLLGAFENTDVGTSLIYGSLLGLAVALFTVIKQGLPMVEIARTLWIGAKSMFGAILILVFAWTIGSVIGDMKTGSYLSTMAQGNINPHWLPVILFLLSGLMAFSTGTSWGTFGIMLPIAGDMAGATDVALMLPMLSAVLAGAVFGDHCSPISDTTILSSTGARCNHIDHVSTQLPYALSVAFVSCIGFITLGMTASIAFSFIAASITFVIVCAILSWLSKSKMASCQNA	61.52	gnl|BL_ORD_ID|1976|hsp_num:0	1969		
AH012710.2|Rubrivivax_18 # 14105 # 14866 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.692	AH012710.2|Rubrivivax_18 	14105	14866	-	Loose	600	24.2534	ICR-Mc	50.0	3004466	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	intrinsic colistin resistant phosphoethanolamine transferase	ATGGGAACCGGTGCCATCACATCCTACGTCGACGTTGCGCAGCTCGTGCTGTACGCCTTCTGGGCGTTCTTCGCGGGCCTTTGCTACTACCTGATCCGCGAGAACCATCGCGAGGGCTACCCTGAAATGGACAGCGGCACGGGCCGCGGTGTCATCACCGGCTGGCCGGTGCCCGAAGCCAAGACGTTCAAGCTGGCCGACGGCCACGAGCACGTCGTGCCGAAGGCCGAAGCGCCGCAGGACAACCTCGCCGCCGAACCCGCCCACGGCTGGATCGGTGCCCCGCTGGTTCCGACCGGCAACCCGCTGCTGGCCGGCGTCGGCCCGGGCGCCTGGACCGAGCGTGCCGACCGTCCCGACGTCGACGTCGACGGCAACGTGCGCATCCTGCCGCTGCGCCTGGTCGAAGGCTTCGACGTGGCCAAGCAGGACAACGACCCGCGCGGCCAGCCGGTGATCGGCGCCGACGGCGTGCAGGCCGGCACGGTGACCGACCTGTGGGTCGACACGCCGGAAAACCTGTTCCGCTACATCGAGGTCGAGCTGACCGGCGGTGCCCGCAAGGTGCTGCTGCCGGTGAACTTCGCGATCCTCAAGCGTGACGCGGTCAAGGTCACGGCGCTGCTGGGCCACCAGTTCGCCGACGTCCCGGCGACCAAGCATCCCGAGCAGGTCACGATGCTCGAGGAAGAGAAGATCTGCGCCTACTACGGCGCCGGCACGCTGTACGCCGAGCCCTCGCGGCAGGAGCCCCTGCTGTGA	MGTGAITSYVDVAQLVLYAFWAFFAGLCYYLIRENHREGYPEMDSGTGRGVITGWPVPEAKTFKLADGHEHVVPKAEAPQDNLAAEPAHGWIGAPLVPTGNPLLAGVGPGAWTERADRPDVDVDGNVRILPLRLVEGFDVAKQDNDPRGQPVIGADGVQAGTVTDLWVDTPENLFRYIEVELTGGARKVLLPVNFAILKRDAVKVTALLGHQFADVPATKHPEQVTMLEEEKICAYYGAGTLYAEPSRQEPLL	MSLKHNQTHNTTFTKFLKSNSFWSKGFWSNRHHRTKDLKGLDAYLFMAIVAIFLTTTANVTFFQQVMSVYPLANYAPFIASLAVVLTGVLLLLLVLLGYRHTLKTVAICFILIAAFAGHFTDTYGTVYDTTMLQNALQTDTAETKDLLSMKLLIRVVLLAGLPICWIIGQPLSFGTLKASLMKRLVTYLVALALVGLPILAFSSQYASFFREHKPLRFFTNPVTVMYSAGKLANMSYKNATKPTETIMHANDAIQKTTASTRKPRLVVMVVGETARADHASFNGYQRATFPHMDKLIGLGQVHNFGNVTSCGTSTAYSVPCMFSYLGAEKYDVDTADYHENVIDTLDRLGVAILWRDNNSDSKGVMNRLPAKQYQDYKNSPLQGGNNTICHTNPYDECRDVGMLVDLDDHVKAHANQDILIVLHQMGNHGPAYYKRYDDEFAQFLPVCTSSELAECERQTVINAYDNALLATDDFLKQTIDWLAAQTHADTAMLYLSDHGESLGEKGVYLHGMPKAFAPKEQLSIPALLWLGADTPFAVANSPTAGFSHDAITPTLLNLFDVSTQATADKTAFVNPLD	43.77	gnl|BL_ORD_ID|2575|hsp_num:0	2902		
AH012710.2|Rubrivivax_19 # 14892 # 16358 # -1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.708	AH012710.2|Rubrivivax_19 	14892	16358	-	Loose	700	25.7942	ACT-17	50.0	3001838	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	GTGGAAGCGCACGTGAAGGCGACCACGGCCCTGCCCGACCCGCTGCGCGAATGGCTGCAGCGCGTCGTGCCGCGCCTGATGCCTTTCGCCGACGCGGCGAGCCCCGGGCTGCCGCTGCCGCGCCTGCTGCGCCTCGCGCTGTTCCAGGTTTCGGTCGGCTTGGCCACCGCGCTGCTGGTCGGCACGCTCAACCGCGTGATGATCGTCGAGCTGGGCGTTCACGCCTGGATCGTCTCGATCATGGTCGCGCTGCCGATGCTGGCCGCGCCCTTCCGCGCCTTCGTCGGCTTCCGCTCCGACGTGCACGCCTCGGTCATCGGCTGGCGCCGCGTGCCCTACATCTGGCTGGGCACGCTGATGCAGTTCGGCGGCCTGGCGATCATGCCGTTCGCGCTGCTGGTGCTGACCGGCCAGGGCCAGCTCGGCCTGGGCTGGGTCGGCCAGATCTGTATCTTCGCCGGCATCTCGTTCCTGCTGGTCGGTGCCGGCCTGCAGACGACGCAGACCACCGGCCTGGCGCTGGCCACCGACCTGGCCAGCGAAGAGTCCCGCCCGCGCGTCGTCGCGCTGATGTACGTGATGCTGCTCGTCGGCCTGGTCGGCGGCGGCATGACCTGCTCGGCGCTGCTGTCGGACTTCTCCGAGCAGCGCCTGGTGCAGGTCGTCCAGGGCGCTGCGGTGCTGACGATCGCGCTGAACCTGCTGGCCGTCTGGAAGCAGGAGGCGCGTGACCCGAACCGCCGCCGCAGCAAGAACCAGCCGGCGCCGGAGTTCCGCACGATGTGGCGCGGCTTCATCGAGCAGCCGCAGGCCAAGCGCTTCCTCTGGATGGTCGGCCTGGGCACGGTGGCCTTCAACATGCAGGACATCGTGCTCGAGCCTTACGGCGGCGAGATCCTGAAGCTGAGCGTCAGCGCCACCAGCACGCTGACGGCGCTGCTGGCCGGCGGTGCGCTGGTCGCCTTCGCGCTGGCCGCCCGCATGCTGGCACGCGGCTGGGATCCGCTGCGTGTCGCGGCGCTGGGCGCCGTCTGCGGCCTGCCGGCTTTCGCGCTGGTGGTCTTCGCCGCGCCGTTGGAGTCACCGGCGATGTTCCGCATCGGCACGGTGCTGATCGGTTTTGGAAGCGGTCTGTTCTCGGTCGGCACGCTGACGGCGGCGATGGGAATGGAGCGCAAGGAACACGTCGGTCTGGCCCTCGGCGCCTGGGGCGCCGTGCAGGCCACGGCGGCCGGCGGTGCGGTTGCAGCCGGCGGCGCGATGCGCGACCTCGTGTCGAGCATGGCGACGCAGGGCCTGCTGGGCCAGGTGCTGGTCAGCCCCGTGACCGGCTACAGCTTCGTCTATCACCTCGAGATGATTCTGCTGTTCGCGGCGCTGGTCGCGATCGGCCCGCTGGTGCGCCGCGCGGGGCGGCGGCAGCAGCCTGAGCAAAACCAATTCGGACTGGCCGATTTCCCCGGCTAG	MEAHVKATTALPDPLREWLQRVVPRLMPFADAASPGLPLPRLLRLALFQVSVGLATALLVGTLNRVMIVELGVHAWIVSIMVALPMLAAPFRAFVGFRSDVHASVIGWRRVPYIWLGTLMQFGGLAIMPFALLVLTGQGQLGLGWVGQICIFAGISFLLVGAGLQTTQTTGLALATDLASEESRPRVVALMYVMLLVGLVGGGMTCSALLSDFSEQRLVQVVQGAAVLTIALNLLAVWKQEARDPNRRRSKNQPAPEFRTMWRGFIEQPQAKRFLWMVGLGTVAFNMQDIVLEPYGGEILKLSVSATSTLTALLAGGALVAFALAARMLARGWDPLRVAALGAVCGLPAFALVVFAAPLESPAMFRIGTVLIGFGSGLFSVGTLTAAMGMERKEHVGLALGAWGAVQATAAGGAVAAGGAMRDLVSSMATQGLLGQVLVSPVTGYSFVYHLEMILLFAALVAIGPLVRRAGRRQQPEQNQFGLADFPG	MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYPNPARVEAAYHILEALQ	128.08	gnl|BL_ORD_ID|1046|hsp_num:0	1114		
AH012710.2|Rubrivivax_20 # 16343 # 17044 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.741	AH012710.2|Rubrivivax_20 	16343	17044	-	Loose	300	43.1282	Erm(37)	51.16	3000392	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGACAACACCAGCTATCAGAACCGCCGCGGCGAGGTCGAGCACTACTTCGACCGCACCGCCGCCCAGACCTGGGCGCGGCTGACCTCCGACGCCCCCGTCAGCGGCGTGCGCGCCACCGTGCGCGCCGGCCGCGACCGCATGCGCACGACGCTGCTGTCGTGGCTGCCGCAGGACCTGCGCGGCCGGCGCGTGCTCGACGCCGGCTGCGGCACCGGCGCGGCCTCGATCGAGCTCGCGCGCCGCGGCGCCGAGGTCGTCGCGATCGACCTGTCGCCGACGCTGGTCGGCTACGCCCGCGAGCGCCTGCCCGAGTCGCTGGGCCCGGGCTCGATCGACTTCCGCAGCGGCGACATGCTCGACCCGGCGCTCGGCCGCTTCGACCACGTCATCGCGATGGACTCGGTGATCCACTACGACGCGCCCGACGCCGTCGCGGCGCTGTCCCGGCTCGCCGAGCGCACCTCGACCTCGATGGTCTTCACCTTCGCGCCGCGCACCGCGCTGCTGTCGCTGATGTGGACCGTCGGCAAGGTGTTCCCGCGCGGCGACCGCTCGCCGGCCATCGTCCCGGTGGCGCCCGAGCAGCTGCGTGCCCTGATGGCCGCGCACCCGGGCCTCAAGGACTGGCAGTGGGGCCGCAGCGAGCGCATCTCCAGCGGCTTCTACACCTCGCAGGCCACGGAGTGGAAGCGCACGTGA	MDNTSYQNRRGEVEHYFDRTAAQTWARLTSDAPVSGVRATVRAGRDRMRTTLLSWLPQDLRGRRVLDAGCGTGAASIELARRGAEVVAIDLSPTLVGYARERLPESLGPGSIDFRSGDMLDPALGRFDHVIAMDSVIHYDAPDAVAALSRLAERTSTSMVFTFAPRTALLSLMWTVGKVFPRGDRSPAIVPVAPEQLRALMAAHPGLKDWQWGRSERISSGFYTSQATEWKRT	MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAVELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLVAADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR	130.17	gnl|BL_ORD_ID|434|hsp_num:0	468		
AH012710.2|Rubrivivax_21 # 17050 # 18027 # -1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.662	AH012710.2|Rubrivivax_21 	17050	18027	-	Loose	2300	28.4906	evgS	31.43	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTATACGAAGGAACTCCAGCATGACGATGACCCGGGGGCAGTACGCCCGGATGACGGAGACGCAGGCATGAACACCGCCACGATCTCCCCCAGCCAGATCGGCCGCGGCGGACGCCCGGACGGCGAAGGCAGCGTGCAGGTGCAGATGGAGACCGGCGCCAAGATCGGCAACGCCAAGGTGTTCGCGATCTACGGCAAGGGCGGCATCGGCAAGAGCACGACCTCCAGCAACCTGTCGGTGGCCTTCAGCAAGCTCGGCAAGCGCGTGCTGCAGATCGGCTGCGACCCGAAGCACGACTCGACCTTCACGCTGACCAAGCGCATGGTGCCCACCGTCATCGACGTGCTCGAGACGGTGAACTTCCATCCCGAGGAACTGCGTGTCGAGGACTTCGTCTTCGAAGGCACCAACGGCGTGATGTGCGTCGAGGCCGGCGGCCCGCCCGCGGGCACCGGCTGCGGCGGGTACGTCGTCGGCCAGACCGTCAAGCTGCTCAAGGAGCACCACCTGCTCGAAGAGACCGACGTCGTCATCTTCGACGTTCTCGGCGACGTGGTCTGCGGCGGTTTCGCCGCCCCGCTGCAGCACGCCGACCGCGCGCTGATCGTCACCGCCAACGACTTCGACTCGATCTTCGCCGCCAACCGCATCGTCCAGGCGATCGGTGCCAAGGCCAAGAACTACAACGTGCGCCTGGGCGGCATCATCGCCAACCGCTCCGACGCCACCGACCAGATCGACAAGTTCAACGACCGCATCGGCATGCGTTCTCTGGCGCGCATCCCGGCGCTGGACGTCATCCGCAAGAGCCGGCTGAAGAAGGCCACGCTGTTCGAGATGGACGACAGCCCCGAGGTGCGTGCGGTGCAGGCCGAATACCTGCAGCTCGCGCAGCGCCTGTGGGACGGCGTCGACCCGCTGTACTGCGAGCCGCTGAAGGACCGCGACATCTTCGACCTGCTGGGCTTCGACTGA	MYTKELQHDDDPGAVRPDDGDAGMNTATISPSQIGRGGRPDGEGSVQVQMETGAKIGNAKVFAIYGKGGIGKSTTSSNLSVAFSKLGKRVLQIGCDPKHDSTFTLTKRMVPTVIDVLETVNFHPEELRVEDFVFEGTNGVMCVEAGGPPAGTGCGGYVVGQTVKLLKEHHLLEETDVVIFDVLGDVVCGGFAAPLQHADRALIVTANDFDSIFAANRIVQAIGAKAKNYNVRLGGIIANRSDATDQIDKFNDRIGMRSLARIPALDVIRKSRLKKATLFEMDDSPEVRAVQAEYLQLAQRLWDGVDPLYCEPLKDRDIFDLLGFD	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	27.15	gnl|BL_ORD_ID|1243|hsp_num:0	1318		
AH012710.2|Rubrivivax_22 # 18002 # 19417 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=CCCCCC;rbs_spacer=15bp;gc_cont=0.700	AH012710.2|Rubrivivax_22 	18002	19417	-	Loose	550	26.1794	SHV-32	39.47	3001090	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	ATGCTGATGTCGATGGCCGGCGACACGCCGCCGGAGCGTTCGGTGGTCGAGGCCATCGTTGCCGGCAAGGCCGTCAGCGGCCACGACGACCTGGTGCGCGCCAACAAGCTGCTGGCCCAGGACACCGAGGTGCCGGGCATCCTGCGTGCGCTCGACGGCCGCTTCGTGCCGCCGGCGCCGGGCGGCGACCTGCTGCGCACGCCCGAGGTGCTGCCCACCGGCCGCAACCTGCATGGCTTCGACCCGTTCCGCATCCCCAGCGCCTTCGCCGTCAAGGACGGCACGCGCCTGGCGCAGCTGCTGCTGGACCGCCACGTCGCCGACGGCAACGCGCTGCCGGAATCGGTCGCGCTGGTGCTCTGGGGCACCGACAACCTGAAGACCGAAGGCGGCCCGATCGGCCAGGCGCTGGCGCTGATGGGCGCGACGCCGCGCTTCGACAGCTACGGCCGGCTGGCCGGCGCGACGCTGATCCCGCTGGAACAGCTGGGCCGCCCGCGTGTCGACGTCGTCATCACGCTGTCGGGCATCTTCCGCGACCTGCTGCCGCTGCAGATCAAGCTGCTGGCCGAGGCCGCTTACCTGGCCGCCACCGCCGACGAGCCGGCCGAGCAGAACTTCGTGCGCAAGCACGCCCTGGCCTACATGCAGCAGCACGGCTGCGACATGGAGACCGCCGCGCTGCGCGTCTTCGGCAACGCCGACGGCACCTACGGCTCCAACGTCAACAACCTGGTCGAGAACGGCCGCTGGGACGACGAGGACGAACTCGCCGAGACCTACAGCCGCCGCAAGGGCTTCGCCTACGGCCGCGCCGGCAAGCCGATGCAGAAGGCCGAGTTGCTGCAGAGCGTGCTCGCCGACGTCGACCTCGCGTACCAGAACCTCGACTCGGTCGAGCTGGGCGTGACGACGATCGACACCTATTTCGACACTCTGGGCGGCATCAGCCGCGCGGTGCGCCGCGCCAAGGGCGGCACCGCGACGCCGGTCTACATCGGCGACCAGACCAAGGGCGACGGCACCGTGCGCACGCTGTCCGAGCAGGTCGCGCTGGAGACCCGCACGCGCATGCTCAACCCGAAGTGGTACGAAGGCATGCTGGAGCACGGCTACGAAGGCGTGCGCCAGATCGAGGTCCACGTGACCAACACGATGGGCTGGTCGGCGACGACCGGCCAGGTGCAGCCCTGGGTCTACCAGCAGCTCACCGAGACCTTCATGCTCGACCCCGAGATGCGCGAGCGCCTCGCGCGTCTGAACCCGGCCGCCTCGGCGAAGGTGGCCAACCGCCTGATCGAAGCGTCCGAGCGCCAGTACTGGAGCCCGGACCCTGAAGTGCTCGAAGCCCTGCGCCGCGCCGGCGAAGAGCTGGAAGACCGCCTCGAAGGTGTATACGAAGGAACTCCAGCATGA	MLMSMAGDTPPERSVVEAIVAGKAVSGHDDLVRANKLLAQDTEVPGILRALDGRFVPPAPGGDLLRTPEVLPTGRNLHGFDPFRIPSAFAVKDGTRLAQLLLDRHVADGNALPESVALVLWGTDNLKTEGGPIGQALALMGATPRFDSYGRLAGATLIPLEQLGRPRVDVVITLSGIFRDLLPLQIKLLAEAAYLAATADEPAEQNFVRKHALAYMQQHGCDMETAALRVFGNADGTYGSNVNNLVENGRWDDEDELAETYSRRKGFAYGRAGKPMQKAELLQSVLADVDLAYQNLDSVELGVTTIDTYFDTLGGISRAVRRAKGGTATPVYIGDQTKGDGTVRTLSEQVALETRTRMLNPKWYEGMLEHGYEGVRQIEVHVTNTMGWSATTGQVQPWVYQQLTETFMLDPEMRERLARLNPAASAKVANRLIEASERQYWSPDPEVLEALRRAGEELEDRLEGVYEGTPA	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAVITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	164.69	gnl|BL_ORD_ID|285|hsp_num:0	306		
AH012710.2|Rubrivivax_23 # 19540 # 19668 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=CCCCCC;rbs_spacer=15bp;gc_cont=0.674	AH012710.2|Rubrivivax_23 	19540	19668	+	Loose	1000	22.7126	MCR-3.2	29.41	3004511	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGCAGCCAGACGATGCCCGCGAGACCGCAGAACACCTCACGCTGCCCGCGTTCGTGCAGGACAGGGGCGTCGCCACAGCCCTGCTGCATCGGGGCAGGGGCGATGTCGATGACGGCATTCATGCGTAG	MQPDDARETAEHLTLPAFVQDRGVATALLHRGRGDVDDGIHA	MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNFVFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPIIVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGRNNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETARGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARNSEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLDSEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTIRYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQVWMSPGFIKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNVQ	7.76	gnl|BL_ORD_ID|2736|hsp_num:0	3139		
AH012710.2|Rubrivivax_24 # 19659 # 20192 # -1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=CCCC;rbs_spacer=14bp;gc_cont=0.631	AH012710.2|Rubrivivax_24 	19659	20192	-	Loose	600	27.7202	OprZ	35.29	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTCCCCGTCTAGATTCTGTGCCATGGGTCACAAGACCAACCTCGATCGCGGACCCACGGCGCCGCGCGTGCCTCCGCTGTACACGCCCGAAGAGCGCATTCGGCGCGACCGCTCGCCCTGGACCATCGTGCAGGGTGTGCTGGCGCCGCTGCAGTTCCTCGTCTTCCTCGTCAGCCTCGTGCTCGTCGTGCGCTACCTGATGACAGGTCAAGGCCACGACGCCGCGACGATCTCGATCGTCATCAAGACGGTGGTGCTCTACACCATCATGATCACCGGCGCGATCTGGGAGAAGGACGTCTTCGGCGTCTACCTCTTCGCCCCCGCCTTCTACTGGGAAGACGTGTTCAGCATGCTCGTACTGGCGCTGCACACGGCCTACCTCGTCGCGCTCACGACTGGCTGGCTTGATGACCGTCAACAAATGTGGCTGGCACTCGCAGCCTACGCGACCTACGTCATTAACGCCGGACAGTTCATCCTTAAGCTGCGGGCCGCGCGATTGAGCGCCCAGTCGGAAGCCTACGCATGA	MSPSRFCAMGHKTNLDRGPTAPRVPPLYTPEERIRRDRSPWTIVQGVLAPLQFLVFLVSLVLVVRYLMTGQGHDAATISIVIKTVVLYTIMITGAIWEKDVFGVYLFAPAFYWEDVFSMLVLALHTAYLVALTTGWLDDRQQMWLALAAYATYVINAGQFILKLRAARLSAQSEAYA	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	38.23	gnl|BL_ORD_ID|2475|hsp_num:0	2796		
